Nadia Dac
Corporate Officer/Principal presso OMEROS CORPORATION
Posizioni attive di Nadia Dac
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OMEROS CORPORATION | Corporate Officer/Principal | 26/01/2021 | - |
Storia della carriera di Nadia Dac
Precedenti posizioni note di Nadia Dac
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 08/04/2019 | 01/06/2020 |
| ABBVIE INC. | Corporate Officer/Principal | 01/12/2014 | 01/03/2019 |
| AUXILIUM PHARMACEUTICALS, INC. | Vendite & Marketing | 01/05/2013 | 01/09/2014 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2009 | 01/01/2013 |
Formazione di Nadia Dac
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Svizzera | 2 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| ABBVIE INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Aziende private | 2 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
- Borsa valori
- Insiders
- Nadia Dac
- Esperienza
